Clinical Trials on Waldenstrom's Disease in France

Total 34880 results

Centre Hospitalier Universitaire, Amiens
Centre Henri Becquerel; University Hospital, Caen; University Hospital, Lille; Centre...

Withdrawn

Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia (SLP-rares)

Waldenstrom Macroglobulinemia | Waldenstrom's Disease

France
Poitiers University Hospital

Recruiting

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

Waldenstrom's Macroglobulinaemia Refractory

France
BeiGene

Recruiting

Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenström's Macroglobulinemia

Waldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

United States, Australia, France, China, Spain, United Kingdom
Eli Lilly and Company

Completed

A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma

Multiple Myeloma | Waldenstrom's Macroglobulinemia

France, United States
Centre Henri Becquerel

Unknown

Detection of Recurrent Mutations in Waldenström's Disease (DigiWAL)

Waldenstrom's Disease

France
BeiGene

Completed

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM) (ASPEN)

Waldenström's Macroglobulinemia

United States, Spain, Australia, France, United Kingdom, Germany, Netherlands, Czechia, Italy, Poland, Belgium, Greece, Sweden
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

Waldenström's Macroglobulinemia

United States, Spain, France, Canada, Germany, Italy, Australia, United Kingdom, Greece
French Innovative Leukemia Organisation

Recruiting

Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease (SérieProWM)

Waldenstrom's Disease | Prognostic Index

France
Mustang Bio
National Cancer Institute (NCI)

Recruiting

Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL

Mantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in Relapse

United States
French Innovative Leukemia Organisation
Institut de cancérologie Strasbourg Europe

Completed

Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 (COVID19_LLC-MW)

Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease

France
French Innovative Leukemia Organisation

Completed

Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia (RemodelWM3)

Waldenstrom Macroglobulinemia

France
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia (WM2)

Waldenstrom Macroglobulinemia

France
Centre Hospitalier Universitaire, Amiens
Centre Henri Becquerel; University Hospital, Caen; University Hospital, Lille; Centre... and other collaborators

Recruiting

Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia (SLPRaresHvisc)

Waldenstrom Macroglobulinemia | Hyperviscosity Syndrome

France
Central Hospital, Nancy, France

Completed

Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia (WAL-KU)

Waldenström Macroglobulinemia

France
Assistance Publique - Hôpitaux de Paris
INSERM UMR 1163

Not yet recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies (GEN-HEMO-INF)

Multiple Myeloma | Waldenstrom Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance

France
University Hospital, Lille
Celgene Corporation

Completed

Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia (RV-WM-0426)

Waldenstrom Macroglobulinemia

France
French Study Group on Chronic Lymphoid Leukemia
French Innovative Leukemia Organisation; Lymphoma Study Association; Département...

Completed

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia | Lymphoplasmacytic Lymphoma

France
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Non-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms Macroglobulinaemia

Poland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
University Hospital, Strasbourg, France

Recruiting

B-cell Chronic Lymphoid Malignancies Markers (MALYZOMA-II)

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia

France
Centre Hospitalier Universitaire de Besancon

Completed

Wind Instruments' Fungal Contamination

Hypersensitivity Pneumonitis | Immunologically-induced Lung Disease

France
Centre Hospitalier Universitaire de Besancon

Unknown

Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients (RIHANNA)

Depression | Alzheimer Disease

France
Centre Hospitalier Universitaire de Besancon

Terminated

Transfer and Ultrafiltration In Peritoneal Dialysis (TULIPE)

End-stage Renal Disease

France
Centre Hospitalier Universitaire de Besancon

Unknown

Multimarker Approach for Acute Dyspnea in Elderly Patients Admitted in the Emergency Department (READ-MA)

Acute Heart Failure | Acute Dyspnea

France
Centre Hospitalier Universitaire de Besancon
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Cryotherapy and Doppler in Inflammatory Rheumatic Diseases (CDRI)

Rheumatoid Arthritis | Spondyloarthritis | Crystal-induced Arthritides

France
Centre Hospitalier Universitaire de Besancon

Unknown

Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer (COBEQOL)

Quality of Life | Metastatic Colorectal Cancer

France
Centre Hospitalier Universitaire de Besancon

Completed

IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA) (IMBASSA)

Breast Cancer | BRCA1 Mutation | BRCA2 Mutation

France
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia

Lymphoma

United States, Australia, United Kingdom, Canada, France
Centre Hospitalier Universitaire de Besancon

Terminated

Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy (RhumatEx)

Arthritis, Rheumatoid

France
Centre Hospitalier Universitaire de Besancon

Completed

Microcirculation During Extracorporeal Circulation (CITRON4)

Mesenteric Ischemia

France
Hopital Jean Minjoz

Unknown

NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure (NGAL-CKF)

Cardiac Surgical Procedures | Preoperative KIDNEY FAILURE, CHRONIC | Postoperative KIDNEY FAILURE, ACUTE

France
Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae (COV-RECUP)

Sars-CoV2

France
Centre Hospitalier Universitaire de Besancon

Completed

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients (TandHER)

Metastatic Cancer | HER2-positive Gastric Cancer | Docetaxel | Trastuzumab

France
Centre Hospitalier Universitaire de Besancon
Pfizer

Active, not recruiting

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma (SURF)

Kidney Neoplasms | Metastatic Renal Cell Cancer

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Influence of Air Pollution on SPondyloarthritis Flare-ups and Resistance to Treatment (SPAIR)

Spondyloarthritis, Axial

France
Centre Hospitalier Universitaire de Besancon

Terminated

Comparison Between High-density Electroencephalography and Conventional Electroencephalography for Comatose Patients (COMETIQUE)

Post Anoxic Coma

France
Centre Hospitalier Universitaire de Besancon

Unknown

Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors (TEXTIS)

Compliance, Patient | Germ Cell Tumor | Follow-up | Text Messaging

France
Kite, A Gilead Company

Recruiting

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)

Relapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell Leukemia

United States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
Daiichi Sankyo France

Recruiting

Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients With HER2+ Breast Cancer

HER2-positive Breast Cancer

France
French National Agency for Research on AIDS and...

Completed

Accelerated Aging, HIV Infection, Antiretroviral Therapies (EP 45)

HIV Infection | Aging Accelerated | Antiretroviral Therapies

France
Centre Hospitalier de Cayenne

Unknown

Diabetes Cohort in French Amazonia (CoDiAm)

Diabetes Mellitus | Adults

France
Centre Hospitalier de Cayenne

Recruiting

Study of Entry and Continuation in Care for People Living With HIV in French Guiana (EMVIH)

Human Immunodeficiency Virus

French Guiana
Centre Hospitalier de Cayenne
European Regional Development Fund

Recruiting

New Tools for Predicting Capillary Leak Shock During Dengue Fever (PrediDengue)

Children | Dengue Fever | Adults

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes Beliefs and Practices Regarding HIV Among Teenagers in French Guiana (CAPADO)

HIV

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes, Beliefs, and Practices Regarding HIV in Populations Living on the Maroni River (CAPMARONI)

HIV

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes Beliefs and Practices Relative to HIV Among Sex Workers in French Guiana (CAPProstit)

HIV

France
Centre Hospitalier de Cayenne
universite de guyane

Completed

Frequency and Distribution of Mixed Falciparum-vivax Infections in French Guiana (MixMal)

Malaria

France
Centre Hospitalier de Cayenne

Completed

Cervical Cancer in French Guiana: Screening Between 2006-2011 (DepCol)

Cervical Cancer

France
Centre Hospitalier de Cayenne

Recruiting

Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana (ParcoursHaiti)

HIV Seropositivity

French Guiana
Centre Hospitalier de Cayenne

Unknown

Registry for End Stage Renal Failure (REIN)

End Stage Renal Failure

France
Acerta Pharma BV

Active, not recruiting

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Waldenström Macroglobulinemia (WM)

Spain, United States, United Kingdom, France, Italy, Greece, Netherlands

Clinical Trials on Waldenstrom's Disease in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations